brimonidine 0.0033 MG/MG Topical Gel [Mirvaso]
RxNorm concept 1437709, branded drug (sbd). Prescribable name: Mirvaso 0.33 % Topical Gel.
- RxCUI
- 1437709
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1437709 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Mirvaso 0.0033 MG/MG Topical Gel; Mirvaso 0.33 % (as brimonidine tartrate 5 mg/ml) Topical Gel
Related concepts
- brimonidine 0.0033 MG/MG (SCDC, consists of)
- brimonidine 0.0033 MG/MG [Mirvaso] (SBDC, consists of)
- Topical Gel (DF, has dose form)
- Mirvaso (BN, has ingredient)
- brimonidine 0.0033 MG/MG Topical Gel (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1437709 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1437709 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1437709. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.